Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -541.66% is 39% below its 5-year average of -389.23%, around the middle of its 5-year range (-806.72%–-281.96%).
4.37% above its 12-month average of -566.43%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -806.72%.
EBITDA MARGIN
-541.66%
EBITDA MARGIN AVG TTM
-566.43%
EBITDA MARGIN AVG 3Y
-420.07%
EBITDA MARGIN AVG 5Y
-389.23%
EBITDA MARGIN AVG 10Y
-363.90%
EBITDA MARGIN AVG 15Y
-383.30%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+4.37%
CURRENT VS 3Y AVG
-28.94%
CURRENT VS 5Y AVG
-39.16%
CURRENT VS 10Y AVG
-48.85%
CURRENT VS 15Y AVG
-41.31%
CURRENT VS 20Y AVG
N/A
InspireMD, Inc.
Market Cap
$28.10M
EBITDA Margin
-541.66%
TTM Avg
-566.43%
3Y Avg
-420.07%
5Y Avg
-389.23%
Market Cap
$25.19M
EBITDA Margin
-710238.40%
TTM Avg
-369696.29%
3Y Avg
-185511.92%
5Y Avg
-193923.76%
Market Cap
$27.99M
EBITDA Margin
-11386.31%
TTM Avg
-11386.31%
3Y Avg
-11386.31%
5Y Avg
-3888.42%
Market Cap
$24.78M
EBITDA Margin
-883.91%
TTM Avg
-2536.80%
3Y Avg
-2479.09%
5Y Avg
-2025.77%
Market Cap
$24.29M
EBITDA Margin
-701.04%
TTM Avg
-599.88%
3Y Avg
-518.61%
5Y Avg
-381.18%
Market Cap
$28.81M
EBITDA Margin
-40038.95%
TTM Avg
-34141.60%
3Y Avg
-20873.74%
5Y Avg
-16727.01%
Market Cap
$29.42M
EBITDA Margin
-706.55%
TTM Avg
-1095.73%
3Y Avg
-881.72%
5Y Avg
-688.00%
Market Cap
$30.52M
EBITDA Margin
-17954.61%
TTM Avg
-17954.61%
3Y Avg
-17954.61%
5Y Avg
-17954.61%
Market Cap
$22.43M
EBITDA Margin
-7.62%
TTM Avg
-5.66%
3Y Avg
-2.78%
5Y Avg
-31.67%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $28.10M | -541.66% | -566.43% | -420.07% | -389.23% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $25.19M | -710238.40% | -369696.29% | -185511.92% | -193923.76% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.99M | -11386.31% | -11386.31% | -11386.31% | -3888.42% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.78M | -883.91% | -2536.80% | -2479.09% | -2025.77% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.29M | -701.04% | -599.88% | -518.61% | -381.18% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.81M | -40038.95% | -34141.60% | -20873.74% | -16727.01% |
| OneMedNet Corporation (ONMD)vs › | $29.42M | -706.55% | -1095.73% | -881.72% | -688.00% |
| GridAI Technologies Corp. (GRDX)vs › | $30.52M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.43M | -7.62% | -5.66% | -2.78% | -31.67% |
| CervoMed Inc. (CRVO)vs › | $29.91M | -10097.04% | -6618.17% | -8743.58% | -8072.84% |
Gross Margin
29.5%
EBITDA Margin
-541.7%
Operating Margin
-547.0%
Net Margin
-355.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -806.72% |
| 2026-03-31 | -406.97% |
| 2025-12-31 | -379.20% |
| 2025-09-30 | -513.04% |
| 2025-06-30 | -726.21% |
| 2025-03-31 | -743.10% |
| 2024-12-31 | -476.76% |
| 2024-09-30 | -463.65% |
| 2024-06-30 | -471.19% |
| 2024-03-31 | -486.10% |
| 2023-12-31 | -326.35% |
| 2023-09-30 | -358.68% |
| 2023-06-30 | -318.80% |
| 2023-03-31 | -349.15% |
| 2022-12-31 | -475.83% |
| 2022-09-30 | -318.66% |
| 2022-06-30 | -302.94% |
| 2022-03-31 | -375.74% |
| 2021-12-31 | -281.96% |
| 2021-09-30 | -372.92% |
| 2021-06-30 | -328.23% |
| 2021-03-31 | -324.35% |
| 2020-12-31 | -2334.81% |
| 2020-09-30 | -220.51% |
| 2020-06-30 | -769.65% |
| 2020-03-31 | -190.52% |
| 2019-12-31 | -243.04% |
| 2019-09-30 | -208.31% |
| 2019-06-30 | -158.42% |
| 2019-03-31 | -745.78% |
| 2018-12-31 | -263.87% |
| 2018-09-30 | -252.67% |
| 2018-06-30 | -143.07% |
| 2018-03-31 | -189.87% |
| 2017-12-31 | -167.83% |
| 2017-09-30 | -284.40% |
| 2017-06-30 | -351.88% |
| 2017-03-31 | -415.11% |
| 2016-12-31 | -510.25% |
| 2016-09-30 | -364.61% |
| 2016-06-30 | -318.33% |
| 2016-03-31 | -352.04% |
| 2015-12-31 | -497.09% |
| 2015-09-30 | -530.22% |
| 2015-06-30 | -512.85% |
| 2015-03-31 | -1009.43% |
| 2014-12-31 | -501.72% |
| 2014-09-30 | -2352.38% |
| 2014-06-30 | -3714.51% |
| 2014-03-31 | -369.70% |
| 2013-09-30 | -247.10% |
| 2013-06-30 | -276.87% |
| 2013-03-31 | -208.72% |
| 2012-12-31 | -318.89% |
| 2012-09-30 | -637.92% |
| 2012-06-30 | -385.53% |
| 2012-03-31 | -271.70% |
| 2011-12-31 | -634.67% |
| 2011-09-30 | -107.55% |
| 2011-06-30 | -207.60% |
| 2011-03-31 | -67.91% |
